Neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PNS)

Clinical trials for Neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PNS) explained in plain language.

Never miss a new study

Get alerted when new Neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PNS) trials appear

Sign up with your email to follow new studies for Neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PNS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New pill hopes to shrink painful nerve tumors in NF1 patients

Disease control Recruiting now

This early-stage trial tests a daily pill called PAS-004 in 56 adults with NF1 who have at least one symptomatic, inoperable plexiform neurofibroma. The study has two parts: Part A finds a safe dose, and Part B checks safety and whether the drug can shrink tumors. Participants ta…

Matched conditions: NEUROFIBROMATOSIS TYPE 1 (NF1)-RELATED PLEXIFORM NEUROFIBROMAS (PNS)

Phase 1 • Sponsor: Pasithea Therapeutics Corp. • Aim: Disease control

Last updated Jun 27, 2026 08:01 UTC

Neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PNS)

Get alerted when new Neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PNS) trials appear

New pill hopes to shrink painful nerve tumors in NF1 patients